LDLR and atherosclerosis: We used standard C57BL/6J laboratory mice that are not ideal for developing atherosclerosis compared to the apoE-/- and the LDLR-/- mouse models [30], making it difficult to determine whether the Aa-HSP60 immunization is atheroprotective or pro-atherogenic.